News Ozempic Comes To India At Rs 2,200 Weekly Dose, Novo Nordisk Cautions Against Unsupervised Use Ozempic has been approved for type-2 diabetes, while Novo Nordisk’s other global blockbuster Wegovy is targeted at obesity.Share this: Share on Facebook (Opens in new window) Facebook Share on X (Opens in new window) X Like this:Like Loading… Post navigation Previous: 8 In 10 Airline Passengers Experienced ‘Dark Patterns’ In 1 year, Mostly On Indigo: SurveyNext: ‘Ready To Discuss, Find Solution’: Centre To Opposition’s Air Pollution Debate Demand In Lok Sabha More Stories News Nagpur Court Convicts LeT Terrorist, Gangster In Nitin Gadkari Extortion Threat Case News Robert Vadra Gets Bail In PMLA Case Linked To Shikohpur Land Deal News ‘Those Who Want To Leave, Can Go’: Mamata’s Message To TMC After Party’s Historic Defeat In Polls